SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E. Mak, J. Zhou, L. C. S. Tan, W. L. Au, Y. Y. Sitoh, N. Kandiah, Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy, Journal of Neurology, Neurosurgery & Psychiatry, 2014, 85, 5, 576

    CrossRef

  2. 2
    In-Uk Song, Sung-Woo Chung, Yong-An Chung, Efficacy of an NMDA receptor antagonist for Parkinson's disease dementia: A brain perfusion SPECT study, International Journal of Imaging Systems and Technology, 2014, 24, 4
  3. 3
    John N. Caviness, Pathophysiology of Parkinson's disease behavior – a view from the network, Parkinsonism & Related Disorders, 2014, 20, S39

    CrossRef

  4. 4
    Nina Benz, Florian Hatz, Habib Bousleiman, Michael M. Ehrensperger, Ute Gschwandtner, Martin Hardmeier, Stephan Ruegg, Christian Schindler, Ronan Zimmermann, Andreas Urs Monsch, Peter Fuhr, Slowing of EEG Background Activity in Parkinson’s and Alzheimer’s Disease with Early Cognitive Dysfunction, Frontiers in Aging Neuroscience, 2014, 6,

    CrossRef

  5. 5
    Amanda-Amrita D. Lakraj, Bahman Jabbari, Duarte G. Machado, Neuronal Networks in Brain Function, CNS Disorders, and Therapeutics, 2014,

    CrossRef

  6. 6
    Banu Ozen Barut, Dilek Ince Gunal, Çiğdem Turkmen, Aynur Mollahasanoğlu, Handan Ankaralı, Clinical and cognitive profiles of patients with both Parkinson’s disease and essential tremor, Acta Neurologica Belgica, 2013, 113, 2, 117

    CrossRef

  7. 7
    Chaorui Huang, Lisa D. Ravdin, Melissa J. Nirenberg, Panida Piboolnurak, Lawrence Severt, James S. Maniscalco, Lilja Solnes, Benjamin J. Dorfman, Claire Henchcliffe, Neuroimaging Markers of Motor and Nonmotor Features of Parkinson's Disease: An [18F]Fluorodeoxyglucose Positron Emission Computed Tomography Study, Dementia and Geriatric Cognitive Disorders, 2013, 35, 3-4, 183

    CrossRef

  8. 8
    Kathleen L. Poston, David Eidelberg, Functional brain networks and abnormal connectivity in the movement disorders, NeuroImage, 2012, 62, 4, 2261

    CrossRef

  9. 9
    Sharon Ash, Corey McMillan, Rachel G. Gross, Philip Cook, Delani Gunawardena, Brianna Morgan, Ashley Boller, Andrew Siderowf, Murray Grossman, Impairments of speech fluency in Lewy body spectrum disorder, Brain and Language, 2012, 120, 3, 290

    CrossRef

  10. 10
    Francesca Di Biasio, Nicola Vanacore, Alfonso Fasano, Nicola Modugno, Barbara Gandolfi, Francesco Lena, Giovanni Grillea, Sara Pietracupa, Giovanni Caranci, Stefano Ruggieri, Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson’s disease-dementia: which matters most?, Journal of Neural Transmission, 2012, 119, 5, 597

    CrossRef

  11. 11
    Yoland Smith, Thomas Wichmann, Stewart A Factor, Mahlon R DeLong, Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa, Neuropsychopharmacology, 2012, 37, 1, 213

    CrossRef

  12. 12
    Samrat Roychowdhury, Duncan R. Forsyth, Sleep disturbance in Parkinson disease, Journal of Clinical Gerontology and Geriatrics, 2012, 3, 2, 53

    CrossRef

  13. 13
    Dario Arnaldi, Claudio Campus, Michela Ferrara, Francesco Famà, Agnese Picco, Fabrizio De Carli, Jennifer Accardo, Andrea Brugnolo, Gianmario Sambuceti, Silvia Morbelli, Flavio Nobili, What predicts cognitive decline in de novo Parkinson's disease?, Neurobiology of Aging, 2012, 33, 6, 1127.e11

    CrossRef

  14. 14
    Liana G. Apostolova, Steven T. DeKosky, Jeffrey L. Cummings, Neurology in Clinical Practice, 2012,

    CrossRef

  15. 15
    Anne Barba, B Changizi, Donald Higgins, Stewart Factor, Eric Molho, Parkinson's Disease, Second Edition, 2012,

    CrossRef

  16. 16
    Naroa Ibarretxe-Bilbao, Carme Junque, Maria J. Marti, Eduardo Tolosa, Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease, Journal of the Neurological Sciences, 2011, 310, 1-2, 70

    CrossRef

  17. 17
    Paulo Bugalho, Teresa Paiva, Dream features in the early stages of Parkinson’s Disease, Journal of Neural Transmission, 2011, 118, 11, 1613

    CrossRef

  18. 18
    Erin R. Foster, Tamara Hershey, Everyday Executive Function Is Associated with Activity Participation in Parkinson Disease Without Dementia, OTJR: Occupation, Participation, Health, 2011, 31, 1, S16

    CrossRef

  19. You have free access to this content19
    K. E. Cruise, R. S. Bucks, A. M. Loftus, R. U. Newton, R. Pegoraro, M. G. Thomas, Exercise and Parkinson’s: benefits for cognition and quality of life, Acta Neurologica Scandinavica, 2011, 123, 1
  20. 20
    John N. Caviness, LihFen Lue, Charles H. Adler, Douglas G. Walker, Parkinson's Disease Dementia and Potential Therapeutic Strategies, CNS Neuroscience & Therapeutics, 2011, 17, 1
  21. 21
    Ericka C. Holmstrand, Susan R. Sesack, Projections from the rat pedunculopontine and laterodorsal tegmental nuclei to the anterior thalamus and ventral tegmental area arise from largely separate populations of neurons, Brain Structure and Function, 2011, 216, 4, 331

    CrossRef

  22. 22
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  23. 23
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  24. 24
    Erin R. Foster, Meghan C. Campbell, Michelle A. Burack, Johanna Hartlein, Hubert P. Flores, Nigel J. Cairns, Tamara Hershey, Joel S. Perlmutter, Amyloid imaging of Lewy body-associated disorders, Movement Disorders, 2010, 25, 15
  25. You have free access to this content25
    Flavio Nobili, Claudio Campus, Dario Arnaldi, Fabrizio De Carli, Gaia Cabassi, Andrea Brugnolo, Barbara Dessi, Silvia Morbelli, Gianmario Sambuceti, Giovanni Abbruzzese, Guido Rodriguez, Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: A [I-123]FP-CIT SPECT study, Movement Disorders, 2010, 25, 1
  26. 26
    Ezequiel Gleichgerrcht, Agustín Ibáñez, María Roca, Teresa Torralva, Facundo Manes, Decision-making cognition in neurodegenerative diseases, Nature Reviews Neurology, 2010, 6, 11, 611

    CrossRef

  27. 27
    Francesca Antonelli, Nicola Ray, Antonio P Strafella, Imaging cognitive and behavioral symptoms in Parkinson’s disease, Expert Review of Neurotherapeutics, 2010, 10, 12, 1827

    CrossRef

  28. 28
    Ann B. Sollinger, Felicia C. Goldstein, James J. Lah, Allan I. Levey, Stewart A. Factor, Mild cognitive impairment in Parkinson's disease: Subtypes and motor characteristics, Parkinsonism & Related Disorders, 2010, 16, 3, 177

    CrossRef

  29. 29
    Birgit Högl, Isabelle Arnulf, Cynthia Comella, Joaquim Ferreira, Alex Iranzo, Barbara Tilley, Claudia Trenkwalder, Werner Poewe, Olivier Rascol, Cristina Sampaio, Glenn T. Stebbins, Anette Schrag, Christopher G. Goetz, Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations, Movement Disorders, 2010, 25, 16
  30. 30
    Chris C. Tang, David Eidelberg, Recent Advances in Parkinson’S Disease - Translational and Clinical Research, 2010,

    CrossRef

  31. 31
    Flavio Nobili, Giovanni Abbruzzese, Silvia Morbelli, Roberta Marchese, Nicola Girtler, Barbara Dessi, Andrea Brugnolo, Cinzia Canepa, Giorgos Chr. Drosos, Gianmario Sambuceti, Guido Rodriguez, Amnestic mild cognitive impairment in Parkinson's disease: A brain perfusion SPECT study, Movement Disorders, 2009, 24, 3
  32. 32
    Turi O. Dalaker, Jan P. Larsen, Niels Bergsland, Mona K. Beyer, Guido Alves, Michael G. Dwyer, Ole-Bjorn Tysnes, Ralph H.B. Benedict, Arpad Kelemen, Kolbjorn Bronnick, Robert Zivadinov, Brain atrophy and white matter hyperintensities in early Parkinson's disease, Movement Disorders, 2009, 24, 15
  33. 33
    Jian Hai, Jue-Feng Wan, Qi Lin, Fei Wang, Lin Zhang, Hui Li, Lan Zhang, Yu-Ying Chen, Yang Lu, Cognitive dysfunction induced by chronic cerebral hypoperfusion in a rat model associated with arteriovenous malformations, Brain Research, 2009, 1301, 80

    CrossRef

  34. You have free access to this content34
    Sarah Jesse, Petra Steinacker, Stefan Lehnert, Frank Gillardon, Bastian Hengerer, Markus Otto, Neurochemical Approaches in the Laboratory Diagnosis of Parkinson and Parkinson Dementia Syndromes: A Review, CNS Neuroscience & Therapeutics, 2009, 15, 2
  35. 35
    K Ray Chaudhuri, Anthony HV Schapira, Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment, The Lancet Neurology, 2009, 8, 5, 464

    CrossRef

  36. 36
    Leslie S. Libow, Pasquale G. Frisina, Vahram Haroutunian, Daniel P. Perl, Dushyant P. Purohit, Parkinson's disease dementia – A diminished role for the Lewy body, Parkinsonism & Related Disorders, 2009, 15, 8, 572

    CrossRef

  37. 37
    Monika Nojszewska, Beata Pilczuk, Beata Zakrzewska-Pniewska, Katarzyna Rowińska-Marcińska, The Auditory System Involvement in Parkinson Disease: Electrophysiological and Neuropsychological Correlations, Journal of Clinical Neurophysiology, 2009, 26, 6, 430

    CrossRef

  38. 38
    Michail E. Kalaitzakis, Ronald K. B. Pearce, The morbid anatomy of dementia in Parkinson’s disease, Acta Neuropathologica, 2009, 118, 5, 587

    CrossRef

  39. 39
    Rufus O. Akinyemi, Njideka N. Okubadejo, Joshua O. Akinyemi, Mayowa O. Owolabi, Lukman F. Owolabi, Adesola Ogunniyi, Cognitive dysfunction in Nigerians with Parkinson's disease, Movement Disorders, 2008, 23, 10
  40. 40
    O. Riedel, J. Klotsche, A. Spottke, G. Deuschl, H. Förstl, F. Henn, I. Heuser, W. Oertel, H. Reichmann, P. Riederer, C. Trenkwalder, R. Dodel, H.-U. Wittchen, Cognitive impairment in 873 patients with idiopathic Parkinson's disease, Journal of Neurology, 2008, 255, 2, 255

    CrossRef

  41. 41
    E. Lyros, L. Messinis, P. Papathanasopoulos, Does motor subtype influence neurocognitive performance in Parkinson’s disease without dementia?, European Journal of Neurology, 2008, 15, 3
  42. 42
    BERTA PASCUAL-SEDANO, JAIME KULISEVSKY, MANEL BARBANOJ, CARMEN GARCÍA-SÁNCHEZ, ANTONIA CAMPOLONGO, ALEXANDRE GIRONELL, JAVIER PAGONABARRAGA, IGNASI GICH, Levodopa and executive performance in Parkinson's disease: A randomized study, Journal of the International Neuropsychological Society, 2008, 14, 05

    CrossRef

  43. 43
    Daniel D. Truong, Roongroj Bhidayasiri, Erik Wolters, Management of non-motor symptoms in advanced Parkinson disease, Journal of the Neurological Sciences, 2008, 266, 1-2, 216

    CrossRef

  44. 44
    Chelsea Stamper, Andrew Siegel, Winnie S. Liang, John V. Pearson, Dietrich A. Stephan, Holly Shill, Don Connor, John N. Caviness, Marwan Sabbagh, Thomas G. Beach, Charles H. Adler, Travis Dunckley, Neuronal gene expression correlates of Parkinson's disease with dementia, Movement Disorders, 2008, 23, 11
  45. 45
    Paul S. Foster, Valeria Drago, David B. FitzGerald, Barry M. Skoblar, Gregory P. Crucian, Kenneth M. Heilman, Spreading activation of lexical–semantic networks in Parkinson's disease, Neuropsychologia, 2008, 46, 7, 1908

    CrossRef

  46. You have free access to this content46
    Mariese A. Hely, Wayne G.J. Reid, Michael A. Adena, Glenda M. Halliday, John G.L. Morris, The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years, Movement Disorders, 2008, 23, 6
  47. 47
    Alireza Kashani, Catalina Betancur, Bruno Giros, Etienne Hirsch, Salah El Mestikawy, Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease, Neurobiology of Aging, 2007, 28, 4, 568

    CrossRef

  48. 48
    J.N. Caviness, J.G. Hentz, V.G. Evidente, E. Driver-Dunckley, J. Samanta, P. Mahant, D.J. Connor, M.N. Sabbagh, H.A. Shill, C.H. Adler, Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease, Parkinsonism & Related Disorders, 2007, 13, 6, 348

    CrossRef

  49. 49
    Nuria Caballol, Maria J Martí, Eduardo Tolosa, Cognitive dysfunction and dementia in Parkinson disease, Movement Disorders, 2007, 22, S17
  50. 50
    Chaorui Huang, Paul Mattis, Chengke Tang, Kenneth Perrine, Maren Carbon, David Eidelberg, Metabolic brain networks associated with cognitive function in Parkinson's disease, NeuroImage, 2007, 34, 2, 714

    CrossRef

  51. 51
    John Stirling Meyer, Juebin Huang, Munir H. Chowdhury, MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias, Journal of the Neurological Sciences, 2007, 257, 1-2, 97

    CrossRef

  52. 52
    A. Wallin, S. Ekberg, K. Lind, V. Milos, A.-K. Granérus, G. Granerus, Posterior cortical brain dysfunction in cognitively impaired patients with Parkinson’s disease – a rCBF scintigraphy study, Acta Neurologica Scandinavica, 2007, 116, 6
  53. 53
    Rita Moretti, Paola Torre, Cristina Vilotti, Rodolfo M. Antonello, Gilberto Pizzolato, Rivastigmine and Parkinson dementia complex, Expert Opinion on Pharmacotherapy, 2007, 8, 6, 817

    CrossRef

  54. 54
    M. Emre, Treatment of dementia associated with Parkinson's disease, Parkinsonism & Related Disorders, 2007, 13, S457

    CrossRef

  55. 55
    Murat Emre, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  56. 56
    Dennis J. Zgaljardic, Joan C. Borod, Nancy S. Foldi, Paul J. Mattis, Mark F. Gordon, Andrew Feigin, David Eidelberg, An Examination of Executive Dysfunction Associated with Frontostriatal Circuitry in Parkinson's Disease, Journal of Clinical and Experimental Neuropsychology, 2006, 28, 7, 1127

    CrossRef

  57. 57
    Guido Alves, Jan Petter Larsen, Murat Emre, Tore Wentzel-Larsen, Dag Aarsland, Changes in motor subtype and risk for incident dementia in Parkinson's disease, Movement Disorders, 2006, 21, 8
  58. 58
    Nancy R. Barbas, Cognitive, Affective, and Psychiatric Features of Parkinson's Disease, Clinics in Geriatric Medicine, 2006, 22, 4, 773

    CrossRef

  59. 59
    Craig J. Whittington, John Podd, Steve Stewart-Williams, Memory Deficits in Parkinson’s Disease, Journal of Clinical and Experimental Neuropsychology, 2006, 28, 5, 738

    CrossRef

  60. 60
    Miros??awa Derejko, Jaros??aw S??awek, Dariusz Wieczorek, Bogna Brockhuis, Miros??awa Dubaniewicz, Piotr Lass, Regional cerebral blood flow in Parkinson??s disease as an indicator of cognitive impairment, Nuclear Medicine Communications, 2006, 27, 12, 945

    CrossRef

  61. 61
    M. W. Riepe, J. Kassubek, F. Tracik, G. Ebersbach, Screening for cognitive impairment in Parkinson’s disease – which marker relates to disease severity?, Journal of Neural Transmission, 2006, 113, 10, 1463

    CrossRef

  62. 62
    Mona K. Beyer, Dag Aarsland, Ole Jacob Greve, Jan P. Larsen, Visual rating of white matter hyperintensities in Parkinson's disease, Movement Disorders, 2006, 21, 2
  63. 63
    Basil Ridha, Keith A. Josephs, Young-Onset Dementia, The Neurologist, 2006, 12, 1, 2

    CrossRef

  64. 64
    Hasmet A. Hanagasi, Murat Emre, Treatment of behavioural symptoms and dementia in Parkinson's disease, Fundamental & Clinical Pharmacology, 2005, 19, 2
  65. 65
    Susan Bassett, Psychiatric Issues in Parkinson's Disease, 2005,

    CrossRef

  66. 66
    Geoffrey Lane, Lee Hyer, Gerald Leventhal, Psychiatric Issues in Parkinson's Disease, 2005,

    CrossRef

  67. 67
    Linda R. White, Mari Gårseth, Jan Aasly, Ursula Sonnewald, Cerebrospinal fluid from patients with dementia contains increased amounts of an unknown factor, Journal of Neuroscience Research, 2004, 78, 2
  68. 68
    Lawrence Elmer, Cognitive issues in Parkinson's disease, Neurologic Clinics, 2004, 22, 3, S91

    CrossRef

  69. 69
    Barbara Collins, John Constant, Samer Kaba, C Lynn Barclay, Erich Mohr, Dementia with Lewy Bodies, Clinical Neuropharmacology, 2004, 27, 6, 281

    CrossRef

  70. 70
    Andrew H Evans, Andrew J Lees, Dopamine dysregulation syndrome in Parkinson??s disease, Current Opinion in Neurology, 2004, 17, 4, 393

    CrossRef

  71. 71
    Murat Emre, Treatment of Dementia Associated with Parkinson's Disease,